Pages

Sunday, July 8, 2012

FDA Approves Roche Test For Tracking Cytomegalovirus.

The Wall Street Journal Share to FacebookShare to Twitter (7/6, Dooren, Subscription Publication) reports that the Food and Drug Administration yesterday approved Roche Holding's COBAS AmpliPrep/COBAS TaqMan CMV Test, to aid physicians in tracking cytomegalovirus (CMV). A result showing a decline in the virus would indicate a successful treatment, while an increase would indicate that a different treat should be tried. The virus is common and is frequently found in patients with transplanted organs.
        Reuters Share to FacebookShare to Twitter (7/6, Siddiqui) reports the test is for use on organ transplant patients being treated for CMV. The FDA said that the test cannot be used to diagnose CMV infection.

No comments:

Post a Comment